Form 8-K - Current report:
SEC Accession No. 0001161697-24-000233
Filing Date
2024-05-15
Accepted
2024-05-15 17:05:11
Documents
13
Period of Report
2024-05-03
Items
Item 4.01: Changes in Registrant's Certifying Accountant

Document Format Files

Seq Description Document Type Size
1 FORM 8-K FOR 05-03-2024 form_8-k.htm   iXBRL 8-K 24564
  Complete submission text file 0001161697-24-000233.txt   195674

Data Files

Seq Description Document Type Size
2 INLINE XBRL SCHEMA FILE ntrr-20240503.xsd EX-101.SCH 3021
3 INLINE XBRL LABEL FILE ntrr-20240503_lab.xml EX-101.LAB 34240
4 INLINE XBRL PRESENTATION FILE ntrr-20240503_pre.xml EX-101.PRE 22363
16 EXTRACTED XBRL INSTANCE DOCUMENT form_8-k_htm.xml XML 3530
Mailing Address 2500 CITYWEST BLVD. STE 150-161 HOUSTON TX 77042
Business Address 2500 CITYWEST BLVD. STE 150-161 HOUSTON TX 77042 (702) 793-4121
NEUTRA CORP. (Filer) CIK: 0001512886 (see all company filings)

EIN.: 274505461 | State of Incorp.: WY | Fiscal Year End: 0131
Type: 8-K | Act: 34 | File No.: 000-55077 | Film No.: 24952397
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)